NeuroMetrix, Inc. (NURO) — Earnings Call X-Ray
Our AI read all 33 of NURO's earnings calls (2016–2024) and answered the same battery of questions about each one. Every past call is free; the newest quarter unlocks with a free account.
Previous Call Grade
D
Q4 2023
Calls Analyzed
33
2016–2024
Avg Candor
7.2/9
evasion 2.4/9
Call-by-call analysis
🔒 Q2 2024 earnings call
2024-08-10
NEWEST
Guidance: ■■■■■Demand: ■■■■■■
Margins: ■■■■Backlog: ■■■■
■ analysts, ■■ questionsexpected move ±■■%
Management ■■■■■■ guidance against ■■■■■■■■ demand and ■■■■■■■ margins. The delivery was ■■■■■■■■ and ■■■■ in specifics, with ■■■ questions left hanging.
🔒 The Q2 2024 call grade is ready
The full 37-point AI read of NURO's newest earnings call — grade, expected move, and every question answered — is free with an account.
Sign up free to unlock
D
Q4 2023 earnings call
2024-02-22
move ±16.8%
Management gave no formal guidance against mixed demand signals and contracting margins. The delivery was unusually candid, rich in specifics.
Demand: mixedMargins: contractingPricing: raisingHeadcount: growing 2 analysts · 4 questions
⚑ Critic ammunition⚑ Question left hanging✓ Early product, fast growthFounder-ledHidden segmentDirection beats results
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
YES Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
YES Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
YES Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
YES Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?
C
Q3 2023 earnings call
2023-10-27
move ±16.3%
Management gave no formal guidance against slowing demand. The delivery was unusually candid, rich in specifics.
Demand: slowingMargins: stablePricing: under pressureHeadcount: growing
⚑ Critic ammunition⚑ Question left hanging✓ Early product, fast growth⚑ Reads rehearsedFounder-ledHidden segment
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
YES Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
YES Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
YES Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
YES Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?
C
Q2 2023 earnings call
2023-07-27
move ±10.1%
Management gave no formal guidance against mixed demand signals. The delivery was unusually candid, rich in specifics.
Demand: mixedMargins: stablePricing: stableHeadcount: growing 2 analysts · 5 questions
⚑ Critic ammunition⚑ Question left hanging✓ Early product, fast growth⚑ Reads rehearsedFounder-ledHidden segment
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
YES Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
YES Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
YES Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?
F
Q1 2023 earnings call
2023-05-03
move ±12.7%
Management lowered guidance against mixed demand signals and contracting margins. The delivery was unusually candid.
Guidance: loweredDemand: mixedMargins: contractingPricing: stableHeadcount: flat 1 analysts · 7 questions
⚑ Critic ammunition⚑ Question left hanging⚑ Reads rehearsedFounder-ledHidden segmentDirection beats results
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
YES Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
YES Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
YES Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?
D
Q4 2022 earnings call
2023-02-23
move ±11.7%
Management gave no formal guidance against mixed demand signals and contracting margins. The delivery was unusually candid, rich in specifics.
Demand: mixedMargins: contractingPricing: under pressureHeadcount: growing 1 analysts · 1 questions
⚑ Critic ammunition⚑ Question left hanging✓ Volume step-up ahead⚑ Reads rehearsedFounder-ledHidden segment
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
NO Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
YES Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
YES Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
YES Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
YES Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?
C
Q3 2022 earnings call
2022-10-20
move ±16.2%
Management gave no formal guidance against mixed demand signals and contracting margins. The delivery was unusually candid, rich in specifics.
Demand: mixedMargins: contractingPricing: under pressureHeadcount: growingCapex: increasing 2 analysts · 2 questions
⚑ Critic ammunition⚑ Question left hanging✓ Resolves doubts⚑ Reads rehearsedFounder-ledHidden segment
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
YES Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
YES Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
YES Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?
D
Q2 2022 earnings call
2022-07-21
move ±16.6%
Management gave no formal guidance against mixed demand signals and contracting margins. The delivery was unusually candid, rich in specifics.
Demand: mixedMargins: contractingPricing: under pressureHeadcount: growingCapex: increasing
⚑ Critic ammunition⚑ Question left hanging⚑ Reads rehearsedFounder-ledHidden segmentDirection beats results
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
YES Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
YES Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
YES Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?
Earlier calls
| Call | Date | Grade | Guidance | Demand | Margins | Candor | Evasion |
|---|
| Q1 2022 |
2022-04-26 |
C+ |
maintained | accelerating | contracting |
8/9 |
1/9 |
| Q4 2021 |
2022-01-27 |
C |
none | mixed | contracting |
7/9 |
2/9 |
| Q3 2021 |
2021-10-21 |
D |
none | stable | contracting |
7/9 |
2/9 |
| Q2 2021 |
2021-07-22 |
C |
maintained | mixed | expanding |
7/9 |
1/9 |
| Q1 2021 |
2021-04-22 |
C |
maintained | stable | expanding |
7/9 |
3/9 |
| Q4 2020 |
2021-01-28 |
D |
none | mixed | expanding |
6/9 |
4/9 |
| Q3 2020 |
2020-10-22 |
D |
none | accelerating | expanding |
7/9 |
3/9 |
| Q2 2020 |
2020-07-23 |
C |
lowered | slowing | expanding |
8/9 |
1/9 |
| Q1 2020 |
2020-04-23 |
C |
lowered | slowing | expanding |
8/9 |
1/9 |
| Q4 2019 |
2020-01-27 |
C |
none | mixed | expanding |
7/9 |
1/9 |
| Q3 2019 |
2019-10-17 |
D |
none | mixed | expanding |
7/9 |
4/9 |
| Q2 2019 |
2019-07-18 |
D |
none | slowing | contracting |
8/9 |
4/9 |
| Q1 2019 |
2019-04-26 |
F |
none | mixed | unclear |
7/9 |
5/9 |
| Q4 2018 |
2019-01-24 |
D |
none | mixed | expanding |
8/9 |
2/9 |
| Q3 2018 |
2018-10-17 |
C+ |
maintained | mixed | expanding |
7/9 |
2/9 |
| Q2 2018 |
2018-07-19 |
C+ |
maintained | mixed | expanding |
7/9 |
3/9 |
| Q1 2018 |
2018-04-19 |
C+ |
none | stable | expanding |
7/9 |
2/9 |
| Q4 2017 |
2018-01-25 |
C+ |
none | accelerating | contracting |
7/9 |
2/9 |
| Q3 2017 |
2017-10-19 |
D |
maintained | mixed | expanding |
7/9 |
2/9 |
| Q2 2017 |
2017-07-20 |
C |
none | accelerating | contracting |
6/9 |
2/9 |
| Q1 2017 |
2017-04-20 |
C+ |
none | accelerating | expanding |
7/9 |
2/9 |
| Q4 2016 |
2017-01-26 |
C |
none | accelerating | expanding |
7/9 |
3/9 |
| Q3 2016 |
2016-10-20 |
D |
none | accelerating | stable |
6/9 |
3/9 |
| Q2 2016 |
2016-07-21 |
D |
none | accelerating | contracting |
7/9 |
2/9 |
| Q1 2016 |
2016-04-21 |
C+ |
none | accelerating | contracting |
7/9 |
2/9 |
Research question bank — earlier calls
During our 1,600-question research program, batches of experimental hypotheses were tested directly against some of NURO's earlier calls. The YES answers — the rare hits — are shown; click any question to see every company that matched it. Full list: the question bank.
C
Q4 2016 earnings call
2017-01-26
1 more research questions answered NO
How to read this page
The grade is a transparent composite of call quality — candor, specificity, low evasion, low stress, whether the call resolves more doubts than it creates, and the guidance action — not a buy or sell signal. The expected move is a volatility estimate from the one signal that survived our out-of-sample tests: how a stock's own reaction and pre-call volatility predict the size (not direction) of its next move. Full detail, including everything that failed: methodology.
Companies with similar call quality
← NUMIF All “N” companies
NUS →
Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our
methodology.